Quick hello: the setup that saves us both time

• To get us started, please tell us your role and the primary team you'll be representing in this research conversation Options: VP / Head of Consumer Insights, Brand Director / Manager, Product Lead / Manager, Innovation Manager, Strategy / Growth, Other
• Which industry best describes your business unit for this project? Options: Other, CPG / Packaged Goods, Retail, Financial Services, Technology, Healthcare
• What triggered you to engage research right now? (pick the closest match) Options: New product concept to validate, Brand health decline in a key segment, Pricing decision requiring CFO approval, M&A / portfolio decision, Leadership asked for evidence, Other
• Roughly what budget band are you planning to allocate for the pilot research (estimate is fine)? Options: <$25k, $25k–$50k, $50k–$100k, $100k–$250k, >$250k, Undetermined
• When would you need pilot findings in hand to influence the next business decision or gate? Options: Within 2 weeks, 2–4 weeks, 1–2 months, 2–3 months, Flexible / not fixed

Who's got the veto? Let’s map the real power dynamics

• If someone walked into the room tomorrow and said 'stop this study', who would that person be? Options: Chief Marketing Officer, VP Insights / Research Director, Product Chief / Head, Finance / CFO, Legal / Compliance, Other
• Who are the three people whose buy-in matters most for this project to be adopted and acted upon?
• How do those stakeholders typically evaluate external research (what convinces them)? Options: Representative sample & quotas, Robust methodology / validation, Clear, prioritized recommendations, Fast turnaround, Cost-effectiveness, Executive-ready deliverables
• What internal politics or past decisions might push this study off the rails if the findings are inconvenient?
• Who will be the formal sign-off owner for accepting the pilot and greenlighting a full study? Options: VP Insights, Brand Lead, Product Lead, Finance, Head of Research, Other

Which assumptions are we about to challenge (and who might resist)?

• Name one widely held assumption about your customers or market that you suspect might be wrong
• Which internal narratives would be most threatened if the research showed a different truth? Options: Pricing strategy, Target segment definition, Channel investments, Product feature priorities, Brand positioning, Other
• How have your teams reacted the last time research contradicted a preferred plan? Options: Accepted and pivoted, Debated but adapted, Ignored it, Asked for additional studies, Shelved the findings
• Who on your team is best positioned to champion uncomfortable findings and make them actionable?

What’s hiding in your existing evidence — and why hasn’t it helped?

• Which sources of customer evidence do you currently rely on most? Options: Internal surveys, CRM / behavioral analytics, Customer service logs, Third-party syndicated studies, Ad hoc qualitative interviews, None / mainly gut
• How recent and relevant are those sources for the question we're about to answer? Options: Last 3 months, 3–12 months, 1–2 years, Older than 2 years, Varies widely
• Tell us about a time those sources led you to a wrong or incomplete decision—what happened and why did it stick out?
• What failure modes have you seen in past research that we must avoid (sampling skew, leading questions, low response quality, executive discomfort with results, other)? Options: Sampling skew, Poor screener design, Low engagement / satisficing, Unclear success metrics, No decision owner, Other
• If we could only fix one thing about your current evidence ecosystem, what would you prioritize?

If one question could change the roadmap, what would it be?

• What is the single business question you need this pilot to answer to move money or headcount?
• Which customer segments matter most to that question? Options: Core users, Lapsed users, High-value customers, Price-sensitive shoppers, New category adopters, Non-consumers
• What would success look like numerically or behaviorally for this question (e.g., conversion lift %, willingness-to-pay $ amount, share shift)?
• Are there hypotheses you want us to test explicitly (priority list)?
• Which competitor moves or market signals should we hold constant versus treat as variables? Options: Assume current competitors, Model a new entrant, Price changes only, Marketing ramp only, Multiple scenarios—we'll discuss

How will the evidence make someone do something different (and who)?

• What are the concrete decisions that will be made from the pilot findings (pick all that apply)? Options: Proceed to full-scale development, Adjust pricing, Change positioning / messaging, Shift distribution channels, Stop a product idea, Request further testing
• For each decision you selected, what acceptance criteria would convince you to act (specific numbers, segments, or behavioral signals)?
• How will recommendations need to be packaged for cross-functional adoption (e.g., 1-page brief, workshop, executive memo)? Options: Executive one-pager, Cross-functional workshop, Full slide deck + appendix, Interactive dashboard, Other
• If the pilot delivers clear directional evidence but not definitive numbers, would you move to a larger study or pause? Options: Move to larger study, Pause and reassess, Make a constrained decision, Depends on stakeholders

What would make you mistrust the sample, right away?

• Which sampling sources do you prefer or require (pick all that apply)? Options: Proprietary panels, Client CRM recruitment, Intercept in-store / in-app, Social recruitment, Third-party market panels, Other
• Are there hard quotas or demographic/behavioral filters we must hit for findings to be credible?
• What minimum sample size or statistical confidence would you accept for the pilot? Options: N<200 (directional), 200–500, 500–1,000, 1,000+, No firm minimum — quality over quantity
• Do you have any geographic, language, or platform constraints we must honor? Options: Single country / market, Multi-country, English only, Multiple languages, Mobile-only respondents, Other
• What contingency would you expect if recruitment slows or quotas aren't met? Options: Extend fieldwork, Adjust quotas, Broaden screener, Switch panel provider, Pause and review

Design choices that separate noise from action—let's get specific

• Which mixed-method balance do you prefer for this pilot (quantitative scale vs. qualitative depth)? Options: Quant-heavy (80/20), Balanced (60/40), Qual-heavy (40/60), Qual-only pilot, Unsure — advise us
• What instruments are you most comfortable with us using (pick all that apply)? Options: Online survey, Conjoint / trade-off, In-depth interviews, Ethnographic observation, Card sorting / concept tests, A/B behavioral tests
• How prescriptive do you want our acceptance criteria to be in the pilot scope (e.g., flat thresholds vs. directional recommendations)? Options: Clear numeric thresholds, Directional with ranges, Narrative recommendations only, Mix of both
• What are the non-negotiables in deliverables (e.g., topline, methodology appendix, raw data)? Options: Topline summary, Methodology appendix, Raw data / respondent-level, Executive presentation, Workshop facilitation

Timeline, commitments and what breaks the schedule

• What is the absolute latest date when findings must be delivered to avoid missing your business gate? Options: Within 2 weeks, 2–4 weeks, 1–2 months, 2–3 months, Flexible
• Which milestone, if missed, would most likely kill the project (kickoff, recruitment, pilot completion, stakeholder review)? Options: Kickoff, Recruitment, Pilot completion, Stakeholder review / sign-off, Commercial contract sign
• Who needs to be present at the final readout to ensure the recommended actions stick?
• What commercial or procurement steps must happen before we can start fieldwork? Options: PO issued, Contract signed, SOW agreed, Budget approval, Other

How risky is it to surface honest answers here — and where do you stand?

• If the data points strongly against a preferred internal idea, what is the likely reaction? Options: Pivot quickly, Request follow-up research, Politically downplay findings, Escalate to legal/finance, Unsure
• How comfortable is leadership with making decisions based on pilot-level evidence versus waiting for larger studies? Options: Comfortable with pilot evidence, Prefer larger confirmatory study, Mixed — depends on the finding, Not comfortable
• What safeguards would increase your confidence that controversial findings will be accepted (e.g., replication plan, stakeholder workshop, joint analysis review)? Options: Replication plan, Pre-registered analysis, Joint interpretation workshop, Independent audit, Clear pre-agreed decision gates
• What would a successful collaborative process look like to you during the study (communication cadence, checkpoints, stakeholders involved)?

Final check: the first three practical next steps we should lock in

• Of these, which one action must we complete in the next 48 hours to keep momentum? Options: Kickoff meeting scheduled, Draft screener reviewed, Budget/PO confirmed, Stakeholder roster finalized, Other
• Which two people should be on the core project team for rapid decisions (name + role)?
• Is there anything we haven’t asked that would materially affect scope, timeline, or credibility?
• How would you prefer we follow up after you submit this discovery—synchronous call, short draft scope, or a workshop to align stakeholders? Options: Schedule a 30-min call, Send a draft scope for review, Host an alignment workshop, Other

Quick tour: What evidence do you already have?

• How recently has a formal research effort (survey, qual study, analytics deep-dive) been completed that influenced a product or marketing decision? Options: Within the last month, Within the last 3 months, Within the last 6 months, 6–12 months ago, More than a year ago, No formal research recently
• Which of these evidence sources are actively used today? Options: Internal surveys / NPS, Transactional analytics, Third-party syndicated data, Customer support logs, In-depth interviews / ethnography, Concept or packaging tests, None of the above, Other (please specify)
• Who on your team typically consumes those findings and turns them into action? Options: Consumer insights / research, Brand / marketing, Product management, Finance, Sales / commercial, Executive leadership, No one reliably
• Briefly describe the single most recent study or data point you leaned on for a decision and the decision it informed.
• Which parts of your current evidence feel worth preserving versus what you believe must change? Options: Sampling approach, Question framing, Analytical depth, Recruitment source, Timing of fieldwork, None — need a fresh approach, Other (please specify)

Why isn’t what you know actually changing decisions?

• When research falls flat in your org, what usually explains why leaders ignore it? Options: Poor representativeness, Ambiguous recommendations, Conflict with existing roadmap, Timing mismatch, Lack of a clear decision owner, Methodological concerns, Other (please specify)
• Tell us about one time a study's results were dismissed—what specifically was challenged and by whom?
• Which of these descriptions matches the tone of pushback you most often hear? Options: 'That's not our consumer', 'The sample is too small', 'This is interesting but not actionable', 'It contradicts what leadership believes', Openly challenged on methodology, Other (please specify)
• How does it feel internally when evidence is sidelined—frustration, relief, defensiveness, or something else? Give a brief example.
• If we could remove one common reason studies are ignored in your organization, which would move the needle most? Options: Clearer actionable recommendations, Higher sample credibility, Faster turnaround, Stronger stakeholder buy-in, Cost predictability, Other (please specify)

Where the data quietly fails us

• Which failure mode causes the most harm in past studies (pick the top two)? Options: Bad screener criteria, Panel-source bias, Non-response bias, Mis-specified quotas, Leading question wording, Poor field timing, Data processing errors
• How often have you discovered after fieldwork that the recruited profile didn’t match the brief? Options: Almost always, Often, Occasionally, Rarely, Never
• Describe a concrete consequence of a failed sample or bad instrument (e.g., wasted launch budget, delayed gate, internal dispute).
• Which quantitative checks would make you relax about representativeness before analysis (choose all that apply)? Options: Benchmark to census / panel benchmarks, Pre-post weighting plan, Detailed screener audit, Pilot cross-tabs, Source-level response rates, Other (please specify)
• On a scale from 1–5, how risky is an underpowered or biased study for your next decision? Options: 1 — negligible, 2 — low, 3 — moderate, 4 — high, 5 — critical

Who’s listening — and who’s quietly blocking?

• If this study had to land a cross-functional decision, who would be the hardest person to convince? Options: CFO / finance, Head of product, Brand lead, Sales / commercial, Legal / compliance, CEO / executive sponsor, No single blocker
• Who has previously championed research outcomes in your org—and what did they do differently?
• Are there political dynamics or incentives that typically bias how results are interpreted (e.g., attribution to prior programs, budget protection)? Options: Yes — strong incentives, Some — occasional bias, Minimal, None I can think of
• Which stakeholder groups must be engaged before fieldwork starts to prevent post-study disputes? Options: Research/insights, Marketing/brand, Product, Finance, Legal, External agency partners, Other (please specify)
• What format of delivery convinces your toughest skeptics (one-pager with next steps, raw tables, workshop walk-through, interactive dashboard)? Options: One‑page decision memo, Workshops with cross-functional attendees, Interactive dashboard, Full technical appendix with raw data, Executive briefing only

What would actually convince you—no spin, just evidence

• Which of the following outcomes would make you say 'this research changed our decision'? Options: Clear preference shift with margin, Actionable segment showing opportunity, Conjoint results that justify price, Behavioral indicators of intent, Tested messaging that increases conversion
• What quantitative thresholds do you need to see to consider a finding reliable (minimum n, confidence interval, effect size)? Options: Minimum n per cell, CIs ±3–5%, CIs ±6–8%, Effect sizes > practical significance, I need to discuss specifics with you
• How much methodological transparency do you require in the final deliverable (detailed appendix, summary only, raw data access)? Options: Full appendix + raw data, Detailed appendix only, Summary + key tables, Executive summary only
• If a pilot and a full study were proposed, which pilot outcomes would be non-negotiable to proceed to full scale? Options: Screener validation, Recruitment speed/quality, Question clarity, Initial signal of effect, No major sample biases detected
• What timeline boundary must we respect to hit your internal gate or budget decision? Options: < 4 weeks, 4–6 weeks, 6–10 weeks, 10+ weeks

Hidden assumptions we must test (so you don’t get surprised)

• What are the top three assumptions your team is making about the target consumer or market that, if wrong, break the plan?
• Which one of those assumptions would you call 'mission-critical'—the single hypothesis we should try to falsify first? Options: Price sensitivity, Product-market fit for target segment, Channel preference, Message resonance, Purchase triggers
• Have prior studies ever overturned a core assumption? Tell us what happened and how the team reacted.
• Which behavioral measures (actual purchase, intent, simulated choice) are essential to test those assumptions? Options: Stated intent, Behavioral tasks / conjoint, Observed purchase data, Simulated choice experiments, Qual interviews capturing context
• What would be an acceptable early-warning signal in the pilot that says 'we’re on the wrong track'? Options: Low engagement in key tasks, High screener failure rate, Contradictory qualitative themes, No statistically significant signal, Other (please specify)

Locking down practicalities so fieldwork won’t fail

• Which recruitment sources are acceptable to you (panel vendors, customer database, intercept, social ads)? Options: Proprietary panel partners, Client CRM / customers, Intercept at POS, Paid social sampling, Multiple-sourced mix, Other (please specify)
• Are there privacy, legal, or compliance constraints we must design around (e.g., no third‑party data, GDPR, internal consent requirements)? Options: Yes — strict constraints, Some constraints, No significant constraints, Unsure, need legal input
• What quota logic or subgroups are essential to include to make results defensible at the decision moment?
• What incentive structure has worked or failed before for your targets (cash, gift, sweepstakes, charitable donation)? Options: Cash / e-gift, Sweepstakes, Charitable donation, No incentive (low friction), Other (please specify)
• What contingency would you want in place if initial recruitment lags or a key subgroup under-recruits? Options: Extend field duration, Add supplemental panels, Relax non-critical quotas, Increase incentive, Cancel / pivot study
• Are there technical or platform requirements for surveys/interviews (mobile-first, language support, integrations with analytics tools)? Options: Mobile-first, Desktop allowed, Multi-language support, Recordings + transcripts, Analytics integration required, Other (please specify)

Agreeing next steps: what sign-offs will make this study unstoppable?

• Who needs to sign off on the final scope before we launch (names or roles)?
• What budget or procurement constraints should we build into the proposal right away? Options: Fixed budget cap, Flexible within range, Procurement required, Use existing agency budget, Other (please specify)
• Which success signal at the end of the engagement will trigger budget approval for follow-on work? Options: Pilot passes quality gates, Actionable recommendation accepted, Stakeholder workshop leads to roadmap change, Statistical evidence for price/feature change, Other (please specify)
• How do you prefer to stay updated during fieldwork to avoid surprises (weekly snapshots, live dashboard, ad‑hoc alerts)? Options: Weekly snapshot emails, Live dashboard access, Ad-hoc critical alerts only, Daily check-ins during pilot, Other (please specify)
• Is there anything else we should know now to prevent the common failure modes we discussed?

Quick roll call — who should show up?

• Describe the single most important audience we must recruit for this study (title, behavior, purchase role, and why they matter).
• Which of the following attributes are absolute musts for respondents? Options: Primary purchaser/decision-maker, Frequent user (weekly+), Recent purchaser (past 3 months), Non-user but category-aware, Price-sensitive shopper, Household influencer, Subscribed customer/member, Other
• How confident are you that existing labels (e.g., 'heavy user', 'occasional buyer') accurately map to the customer behavior we need to study? Options: Very confident, Somewhat confident, Unsure — need validation, Likely incorrect
• Who in your organization will be the single point of truth for resolving conflicting recruitment trade-offs?

What if your 'target' isn't actually the group making the call?

• If the people we recruit can't actually move the decision you're trying to inform, how would that change the value of this research? Options: Research still useful, Would reduce value significantly, Would invalidate the study, Unsure
• Who influences the decision you care about (e.g., final approver, budget owner, procurement), and how long have they been excluded from your assumptions?
• Are there secondary segments we should include as comparison cells because their behavior often contradicts your primary target? Options: Yes — specify later, No, focus tightly, Maybe — would like recommendation
• How much would you tolerate broadened criteria to preserve representativeness (e.g., relax recency from 3 months to 6 months)? Options: None — strict only, Slight relaxation, Flexible if justified, Open to suggestions

Are your screener questions quietly shrinking the audience?

• Please paste or summarize the current screener logic you plan to use (key inclusion/exclusion rules and critical branches).
• Which screening criteria do you consider negotiable if a cell is underperforming? Options: Age bands, Purchase recency, Platform/channel used, Income band, Self-reported product familiarity, None — all mandatory
• How long should the screener take on average (seconds or minutes) to avoid drop-off and satisficing? Options: Under 30 seconds, 30–90 seconds, 1–3 minutes, 3–5 minutes, Over 5 minutes
• Are there sensitive or legally constrained questions (health, financial, identity) that require special wording or consent? Options: Yes — requires special handling, No

Quotas: real guardrails or a feel-good checklist?

• Which quota types must be enforced to consider the sample representative? Options: Age, Gender, Geography/region, Ethnicity, Purchase frequency, Income/SES, Channel (online/in-store), Other
• What is the minimum acceptable n per quota cell before you’d consider combining or relaxing quotas? Options: 10, 20, 30, 50, 75, 100+
• If a lower-priority quota is blocking recruitment, which should be deprioritized first? Options: Demographic quotas, Behavioral quotas, Attitudinal quotas, Geographic quotas, None — do not deprioritize
• Are there weighting rules you'd accept post-fielding to correct imbalances, or must raw quotas be met? Options: Weighting acceptable, Prefer raw quotas, Case-by-case

Where will we actually find them — panels, partners, or your CRM?

• Which sourcing channels are acceptable for recruitment in this study? Options: Proprietary panels, Syndicated panel vendors, Client CRM/database, Social recruitment/ads, Intercept in-store, Third‑party recruitment partners
• Have you had prior experiences (good or bad) with any suppliers we should avoid or prefer? Options: Prefer supplier A, Avoid supplier B, Open to any high-quality supplier, No prior experience to note
• Do we need signed data-sharing agreements or vendor approvals before fielding begins? Options: Yes — legal needed, No, Unsure — please advise
• What panel metadata do you require to validate quality (e.g., recruitment source, geo IP, time to complete, device)? Options: Recruitment source, Geo IP, Time to complete, Device type, Browser fingerprinting, Panelist ID, Other

Screener fatigue, bots, and speeders — are we prepared?

• What minimum attention-check strategy would make you confident responses are genuine? Options: 2 embedded attention checks, 1 attention check + trap questions, Behavioral flags only (time, IP), Full panelist verification required
• Which automated quality filters are mandatory to reject respondents (e.g., <50% median time, duplicate IPs, straightlining)? Options: Median time cutoff, Duplicate IP/device, Straightlining detection, Open-text gibberish detection, None — manual review preferred
• How quickly should we escalate suspected panel or bot issues to your team? Options: Immediately (real-time), Daily summary, Weekly report, At pilot completion
• Tell us about a past quality failure — what happened and how long did it take to recover?

What if recruitment stalls — do we have a contingency playbook?

• At what point do you want us to trigger contingency actions (e.g., % of target unmet by day X)? Options: 10% behind by mid-field, 25% behind at any point, By day X — specify later, Trigger manually after review
• Which contingency tactics are you willing to approve if cells underperform? Options: Increase incentives, Broaden age/income bands, Use alternate panels, Extend fielding window, Add social recruitment
• Are there substitution rules we must follow (e.g., replace non-qualifying by adjacent quota only)? Options: No substitutions allowed, Substitute adjacent quotas, Substitute only after client sign-off, Open to vendor recommendations
• Who must sign off on contingency changes outside the original SOW?

Timing is the hidden risk — can your timeline tolerate slips?

• What is the immovable deadline (decision gate, launch, board review) that the research must feed?
• What is the latest acceptable date for full data delivery before the decision becomes compromised? Options: Within 1 week of current plan, 2 weeks later, 1 month later, Must be on the planned date
• Which fielding windows are off-limits (holidays, major industry events, fiscal close)? Options: Major holidays, Fiscal close periods, Product launch weeks, None — flexible
• Would you prefer a faster, smaller pilot for proof-of-method before committing to full fielding? Options: Yes — pilot first, No — full field now, Maybe — advise based on risk

How will we prove the sample is believable to skeptics?

• Which QC evidences would settle internal skeptics (e.g., raw panelist lists, paradata, device/IP logs, screener summary)? Options: Raw panelist metadata, Paradata/time stamps, Device/IP logs, Screener branching summary, Third‑party verification report
• What benchmarks or external data sources should our sample align to (e.g., national census, category purchase incidence)? Options: National census, Category purchase incidence, Client CRM benchmarks, No external alignment needed, Other
• If representativeness falls short in one cell, do you prefer refielding that cell, weighting, or transparent caveats in reporting? Options: Refield that cell, Weight and report, Transparent caveats only, Decide case-by-case
• Who in your stakeholder group will require demonstrated QC before accepting findings? Options: Insights lead, Product lead, Finance/CFO, Marketing director, Other

Money talks — are incentives realistic for the audience?

• What is the total incentive budget per completed respondent you’ve allocated (or target incentive range)? Options: Under $2, $2–$5, $5–$10, $10–$25, Over $25
• Are incentives distributed as cash, e-gift, points, or charitable donations? Any restrictions? Options: Cash/PayPal, E-gift cards, Panel points, Charitable donation, Other
• Would you approve higher incentives for hard-to-reach quotas (e.g., niche professionals, low-prevalence groups)? Options: Yes — tiered incentives, No — flat rate only, Open to vendor recommendation
• Do your procurement or compliance rules limit incentive types or require vendor receipts? Options: Yes — restrictions apply, No restrictions, Unsure — need guidance

Who owns final verdicts — and how will disagreements be resolved?

• Who will sign off on the final sample and acceptance criteria before analysis begins?
• If the vendor recommends deviating from the original plan to protect representativeness, who has authority to approve that change? Options: Insights lead, Product lead, Procurement, Cross-functional steering group
• What format of recruitment updates would help you feel in control (daily dashboard, mid-field check, weekly calls)? Options: Real-time dashboard, Daily summary emails, Weekly sync calls, Mid-field checkpoint only
• If late-breaking evidence suggests the sample won't support the decision, what escalation steps do you want us to take? Options: Pause fielding and consult, Continue with caveats, Expand recruitment aggressively, Executive alert required

Pilot test — are we ready to run a smaller dress rehearsal?

• Would you like a pilot focused on recruitment validation (screener efficacy, time-to-complete, quota flow) before full fielding? Options: Yes — strongly prefer, Optional — vendor discretion, No — proceed to full field
• What minimum pilot size would convince you the approach is sound (per cell)? Options: 10, 20, 30, 50
• How quickly do you expect pilot findings and recommended adjustments to be delivered? Options: 48 hours, 3 business days, One week, Other
• If the pilot uncovers fundamental recruitment issues, are you open to revisiting the research question or target definition? Options: Yes — open to revising, Reluctant but possible, No — must keep original scope

Start Here — Who’s in the room and why this matters

• Briefly, what is your role and the team you represent? Options: VP/Head of Consumer Insights, Brand Director, Product Lead/Manager, Innovation Manager, CMO/Marketing Lead, Other (please specify)
• What business trigger brought you to consider primary research right now? Options: New product concept validation, Declining brand health in a segment, Pricing decision required by finance, Channel/market expansion, M&A / portfolio decision, Other
• What is the decision deadline or gate this research must meet? Options: Within 2 weeks, 2–4 weeks, 1–2 months, 2–3 months, Flexible/No firm deadline
• Who must be in the final decision loop (names or roles)? Options: Insights/Research Director, Brand Lead, Product Manager, CFO/Finance Rep, Engineering/Operations, Sales/Channel Lead, External Agency/Partner
• Thinking about the people you just listed—who do you expect will be the strongest supporter and who is most likely to push back? Tell us why.

Before We Assume — what evidence are we building on?

• What if the evidence you currently trust is missing the consumers who actually make the decision—what would that mean for your plan?
• Which existing data sources have you used or referenced so far? Options: Internal survey(s), A/B test or analytics, Sales/CRM data, Third‑party syndicated data, Qualitative interviews, None/We’re starting fresh
• What were the most important findings from those sources and how recent are they?
• How confident are you that those findings reflect the target segment’s current behavior? Options: Very confident, Somewhat confident, Neutral/Unsure, Not confident
• Where do you feel the evidence is weakest—what specific question or assumption keeps you up at night?

Where the Plan Usually Breaks

• What would it look like if this research failed to change the decision—and why might that happen here?
• Which of these risks worry you most for this project? Options: Unrepresentative sample, Too-broad research question, Leadership dismisses results, Timeline slips missing the gate, Budget limits scope, Poor recruitment quality
• Have you run a similar study before that didn’t land—what specifically went wrong and how long ago was it?
• If stakeholders push back on findings, what arguments have historically worked to change minds in your org? Options: Concrete metrics (lift/elasticity), Customer quotes/case studies, Benchmarks vs competitors, Pilot evidence / A/B results, Executive sponsorship
• If we had to be conservative on sample quality, what’s the minimum representativeness threshold you’d accept? Options: Nationally representative, Target segment quotas only, Behavior-based recruitment, Panel-sourced with verification, I need your recommendation

If This Worked, What Would Be Different?

• Imagine two months after delivery—what are the three concrete decisions that should change if the research is persuasive?
• Which metrics or signals would make you say, ‘This is worth acting on’? Options: X% lift in purchase intent, Positive willingness-to-pay delta, Clear segment prioritization, Behavioral intent to switch, Significant unmet need with product fit
• Which internal teams must be convinced for the recommendation to stick, and what proof does each team need? Options: Product, Marketing, Finance, Sales/Channel, Legal/Regulatory, Executive
• What would an ‘actionable insight’ look like to you—describe the format, granularity, or threshold you’d require.
• If the study produces ambiguous results, which fallback decision-making approach would you prefer? Options: Small prototype/pilot, Additional targeted interviews, Refined quantitative wave, Stop and reassess business case

The Right Study for Your Question

• What if the chosen method gives you statistically significant answers but no story you can act on—how would that feel for your team?
• Which research methods are you most open to using here? Options: Quantitative survey, In-depth qualitative interviews, Ethnography/diaries, Conjoint/discrete choice, Behavioral analytics, Mixed-method pilot + full study
• Would you prefer a pilot to de-risk design, or go straight to the full study? Options: Pilot first, Full study only, Flexible based on design
• Who precisely is the sample we must reach (demographics, behaviors, purchase frequency, loyalty tiers)—list the most critical qualifiers.
• Which measures are non-negotiable to include in the instruments? Options: Purchase intent, Price sensitivity/WTP, Usage occasions, Attribute importance, Open-ended needs statements, Other

Recruitment — who exactly must be in the room?

• Are we recruiting the people who actually decide—or just the easiest to find?
• Which segments must be quota‑controlled to ensure defensible findings? Options: Age bands, Income levels, Purchase frequency, Loyalty tier, Geography/region, Channel users (online/in-store)
• What are acceptable panel sources or recruitment approaches for you? Options: Proprietary panel with verification, Field recruitment (in‑market), Client CRM/recontact, Third-party panels (audited), Hybrid approach
• What red flags in screening responses would immediately disqualify a respondent? Options: Speeding thru survey, Inconsistent answers, Gaming attention checks, Wrong geography, Non‑target usage
• How should we handle likely non-response or quota shortfalls—what contingency do you prefer? Options: Extend fielding time, Relax less-critical quotas, Use matched supplemental samples, Pause and redesign screener

Agreeing How We’ll Know It Worked

• If you could only take two findings from this study to the exec team, which would you choose?
• What are the explicit acceptance criteria for the study (sample size, margin of error, QA checks)? Options: Predefined sample size & MOE, Quota completion with verified responses, Qualitative saturation for themes, Pass live QA & bot checks, Client sign-off on instruments
• Which deliverables will be required to make a fast decision after delivery? Options: Executive one-pager, Top 3 actionable insights, Cross-functional workshop, Full technical appendix, Raw data files
• How often would you like checkpoints and what decisions will be made at each (design, pilot review, go/no-go)? Options: Design sign-off, Pilot results review, Mid-fielding quality check, Final delivery & workshop
• Who has final sign‑off authority to accept the findings and move to the next business step? Options: Insights Director, Brand Lead, CFO/Finance, Cross-functional committee, Executive sponsor